This section provides links to policies and other information related to requirements for DAIDS-supported pharmacies and the use of study products associated with DAIDS-supported clinical research that fall within the scope of the policy.
wa09_pharmacy_guidelines_02aug2023_final.pdf (846.96 KB) -
pharmfacilities.pdf (122.71 KB) -
pharmactivities.pdf (84.64 KB) -
pharmpersonnel.pdf (156.35 KB) -
NonFDAapprovedProducts.pdf (194.77 KB)